239 related articles for article (PubMed ID: 21595969)
1. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
[TBL] [Abstract][Full Text] [Related]
3. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence.
Origer A; Schmit JC
J Epidemiol Community Health; 2012 Jan; 66(1):64-8. PubMed ID: 20889592
[TBL] [Abstract][Full Text] [Related]
5. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
Alipour A; Haghdoost AA; Sajadi L; Zolala F
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.
Lamden KH; Kennedy N; Beeching NJ; Lowe D; Morrison CL; Mallinson H; Mutton KJ; Syed Q
J Infect; 1998 Nov; 37(3):260-9. PubMed ID: 9892530
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
8. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
9. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
[TBL] [Abstract][Full Text] [Related]
13. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
[TBL] [Abstract][Full Text] [Related]
14. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics.
Köse Ş; Ödemiş I; Çelik D; Gireniz Tatar B; Akbulut I; Çiftdoğan DY
Infez Med; 2017 Dec; 25(4):339-343. PubMed ID: 29286012
[TBL] [Abstract][Full Text] [Related]
16. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
Edeh J; Spalding P
J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
[TBL] [Abstract][Full Text] [Related]
17. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
18. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
19. Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection.
Dickson-Spillmann M; Haug S; Uchtenhagen A; Bruggmann P; Schaub MP
Eur Addict Res; 2016; 22(4):181-91. PubMed ID: 26656112
[TBL] [Abstract][Full Text] [Related]
20. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]